CA2655596A1 - Systeme de delivrance osmotique multiparticulaire - Google Patents

Systeme de delivrance osmotique multiparticulaire Download PDF

Info

Publication number
CA2655596A1
CA2655596A1 CA002655596A CA2655596A CA2655596A1 CA 2655596 A1 CA2655596 A1 CA 2655596A1 CA 002655596 A CA002655596 A CA 002655596A CA 2655596 A CA2655596 A CA 2655596A CA 2655596 A1 CA2655596 A1 CA 2655596A1
Authority
CA
Canada
Prior art keywords
composition
drug
dissolution medium
aqueous solution
osmotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002655596A
Other languages
English (en)
Other versions
CA2655596C (fr
Inventor
Graham Jackson
Tien Nghiem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Valeant International Bermuda
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2006/024832 external-priority patent/WO2007002597A2/fr
Application filed by Individual filed Critical Individual
Publication of CA2655596A1 publication Critical patent/CA2655596A1/fr
Application granted granted Critical
Publication of CA2655596C publication Critical patent/CA2655596C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2655596A 2006-06-27 2007-06-26 Systeme de delivrance osmotique multiparticulaire Expired - Fee Related CA2655596C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
PCT/US2006/024832 WO2007002597A2 (fr) 2005-06-27 2006-06-27 Formulations a liberation modifiee d'un sel de bupropion
USPCT/US2006/24832 2006-06-27
US11/475,252 2006-06-27
US11/475,252 US7241805B2 (en) 2005-06-27 2006-06-27 Modified release formulations of a bupropion salt
PCT/IE2007/000062 WO2008001341A1 (fr) 2006-06-27 2007-06-26 Système de délivrance osmotique multiparticulaire

Publications (2)

Publication Number Publication Date
CA2655596A1 true CA2655596A1 (fr) 2008-01-03
CA2655596C CA2655596C (fr) 2011-10-25

Family

ID=38512133

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2655596A Expired - Fee Related CA2655596C (fr) 2006-06-27 2007-06-26 Systeme de delivrance osmotique multiparticulaire

Country Status (3)

Country Link
EP (1) EP2032124A1 (fr)
CA (1) CA2655596C (fr)
WO (1) WO2008001341A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190336476A1 (en) * 2016-12-28 2019-11-07 Fujifilm Toyama Chemical Co., Ltd. Pharmaceutical composition
CN115350156A (zh) * 2022-08-26 2022-11-18 丽珠集团丽珠制药厂 一种克拉霉素片及其制备方法

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101534422B1 (ko) 2008-05-14 2015-07-09 오토노미, 인코포레이티드 귀 질환 치료를 위한 제어 방출형 코르티코스테로이드 조성물 및 방법
CA2725482A1 (fr) * 2008-06-09 2009-12-17 Supernus Pharmaceuticals, Inc. Formulations a liberation controlee de pramipexole
US8846770B2 (en) 2008-06-18 2014-09-30 Otonomy, Inc. Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
CN103347506A (zh) 2010-10-12 2013-10-09 约翰.霍普金斯大学 包含美金刚的镇咳组合物
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
US9861585B2 (en) 2012-10-16 2018-01-09 Sun Pharmaceutical Industries Limited Osmotic floating tablets
EP2724709A1 (fr) * 2012-10-24 2014-04-30 Unilever N.V. Composition d'écran solaire contenant des sels de L-DOPA-ester
CN102994477B (zh) * 2012-11-26 2014-09-17 河北省微生物研究所 修饰的米曲霉乳糖酶及其制备方法和应用
CN103142491B (zh) * 2013-02-06 2015-07-15 广东先强药业有限公司 一种单磷酸阿糖腺苷微球给药系统及其制备方法
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
US10195153B2 (en) 2013-08-12 2019-02-05 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
WO2015031393A1 (fr) 2013-08-27 2015-03-05 Otonomy, Inc. Méthodes pour le traitement de troubles otiques chez les enfants
WO2015095391A1 (fr) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Comprimé extrudé anti-abus à libération prolongée
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
CA2955229C (fr) 2014-07-17 2020-03-10 Pharmaceutical Manufacturing Research Services, Inc. Forme posologique remplie de liquide anti-abus a liberation immediate
US9132096B1 (en) 2014-09-12 2015-09-15 Alkermes Pharma Ireland Limited Abuse resistant pharmaceutical compositions
EP3209282A4 (fr) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Forme galénique anti-abus de remplissage de liquide à libération prolongée
CN105935356B (zh) * 2016-03-28 2018-11-13 赤峰赛林泰药业有限公司 一种重酒石酸卡巴拉汀的固体制剂的制备方法
WO2018053173A1 (fr) 2016-09-16 2018-03-22 Otonomy, Inc. Formulations de gel otique pour le traitement de l'otite externe
ES2886067T3 (es) 2016-10-07 2021-12-16 Silvergate Pharmaceuticals Inc Formulaciones de amlodipina
EP3773574A4 (fr) 2018-04-11 2022-03-02 Silvergate Pharmaceuticals, Inc. Formulations d'amlodipine
CN114222561A (zh) * 2019-06-03 2022-03-22 合成生物制品有限公司 碱性磷酸酶制剂及其用途
CN114469904B (zh) * 2022-02-18 2024-04-05 贵州拜乐锦生物技术有限公司 组合物、制备方法及在制备甲板涂敷产品中的应用
CN116251067B (zh) * 2023-04-23 2024-06-07 淄博市中心医院 一种氟康唑片、制备方法及用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698224A (en) * 1994-06-27 1997-12-16 Alza Corporation Tacrine therapy
US8329217B2 (en) * 2001-11-06 2012-12-11 Osmotica Kereskedelmi Es Szolgaltato Kft Dual controlled release dosage form
US20030185882A1 (en) * 2001-11-06 2003-10-02 Vergez Juan A. Pharmaceutical compositions containing oxybutynin
AR040301A1 (es) * 2002-06-28 2005-03-23 Alza Corp Composicion osmotica expansible y suspension para revestimiento mejoradas
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190336476A1 (en) * 2016-12-28 2019-11-07 Fujifilm Toyama Chemical Co., Ltd. Pharmaceutical composition
CN115350156A (zh) * 2022-08-26 2022-11-18 丽珠集团丽珠制药厂 一种克拉霉素片及其制备方法
CN115350156B (zh) * 2022-08-26 2023-11-28 丽珠集团丽珠制药厂 一种克拉霉素片及其制备方法

Also Published As

Publication number Publication date
WO2008001341A1 (fr) 2008-01-03
CA2655596C (fr) 2011-10-25
EP2032124A1 (fr) 2009-03-11

Similar Documents

Publication Publication Date Title
CA2655596A1 (fr) Systeme de delivrance osmotique multiparticulaire
US6893661B1 (en) Controlled release formulations using intelligent polymers
CA2405190C (fr) Forme posologique orale solide de simethicone
US8173161B2 (en) Method of administering a pharmaceutical active ingredient
US7815937B2 (en) Quick dissolve compositions and tablets based thereon
US6013280A (en) Immediate release dosage forms containing microspheres
US20080292700A1 (en) Controlled release formulations using intelligent polymers
EP1260219B1 (fr) Compositions pour l'enrobage par immersion comprenant des éthers cellulosiques
US20040185093A1 (en) Compositions containing sucralose
JP2005535622A5 (fr)
US20090092739A1 (en) Method of dip-coating dosage forms
US9549767B2 (en) Encapsulated screw locking system
CA2724123C (fr) Capsule contenant un agent therapeutique destine aux implants
US9050264B2 (en) Cellulose capsules and methods for making them
NZ527342A (en) Polyacrylic film forming compositions
WO2000009072A2 (fr) Microspheres pouvant etre desintegrees
US20120082729A1 (en) Quick dissolve compositions and tablets based thereon
EP0969817A1 (fr) Formes galeniques aux proprietes de liberation ameliorees

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20200831